Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Copenhagen – page 18

778 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Copenhagen at a glance
778
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

778 trials in Copenhagen

Open in trial search

Retinal artery occlusion

Recruiting

Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Oslo University Hospital HF

Cardiac ventricular thrombosis+1

Recruiting

Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska Institutet

Medulloblastoma

Recruiting

Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:The University Of Birmingham

Hereditary ataxia+1

Recruiting

Study on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington's Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:VO659
  • Sponsor:Vico Therapeutics B.V.

Anaesthetic complication neurological

Recruiting

Evaluating the effects of intravenous melatonin for preventing agitation and emergence delirium in children undergoing elective surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Melatonin
  • Sponsor:Rigshospitalet

Aortic aneurysm

Recruiting

Study on Metformin Embonate to Slow Growth of Small Abdominal Aortic Aneurysms in Patients Without Diabetes

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Embonate
  • Sponsor:Uppsala University

Acute myeloid leukaemia

Recruiting

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Vaestra Goetalandsregionen

Ependymoma

Recruiting

Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Cisplatin
  • Sponsor:Centre Leon Berard

Rhabdomyosarcoma

Recruiting

Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:The University Of Birmingham

Palliative care+1

Recruiting

Study of psilocybin therapy for psychological distress in patients with COPD, ALS, multiple sclerosis, or atypical Parkinson's disorders

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine
  • Sponsor:Universitair Medisch Centrum Groningen

Neuroblastoma

Recruiting

Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:Institut Gustave Roussy

Neoplasm

Recruiting

Study on Repotrectinib for Children and Young Adults with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Alterations

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Repotrectinib
  • Sponsor:Turning Point Therapeutics Inc.

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Copenhagen

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in København includes cardiovascular diseases, with studies focused on acute heart failure. The research is aimed at improving treatment choices and helping clinicians better manage fluid overload and treatment response.

  • Optimizing care for acute decompensated heart failure
  • Evaluating diuretic treatment strategies
  • Addressing risk of diuretic resistance

These trials support more effective day-to-day management of patients with unstable heart conditions.

02 Digestive System Diseases

Research in digestive system diseases is centered on liver cirrhosis and its complications, especially ascites. The main purpose is to improve treatment planning and identify which patients are most likely to benefit from supportive therapy.

  • Studying cirrhosis with ascites
  • Validating response markers for human albumin therapy
  • Improving personalized treatment decisions

This work may help refine care for people with advanced liver disease.

03 Neoplasms

Trials in the field of neoplasms are examining localised dMMR colon cancer. The research is focused on assessing treatment effectiveness and understanding how well patients respond to newer cancer approaches.

  • Investigating colon cancer treatment response
  • Measuring clinical complete response
  • Supporting more tailored cancer care

These studies aim to strengthen precision treatment for selected colorectal cancer patients.

04 Nervous System Diseases

Clinical research in nervous system diseases involves acute ischemic stroke. The goal is to improve urgent stroke care by comparing treatment approaches and their impact on early neurological recovery.

  • Focusing on emergency stroke management
  • Assessing early neurological improvement
  • Comparing current care with thrombolysis approaches

These trials are designed to support faster, more effective treatment decisions after stroke.

05 Virus Diseases

Research in virus diseases includes work on chronic hepatitis B infection, with studies exploring immune-based approaches and treatment effects. The overall aim is to improve control of long-term viral infection and related liver health.

  • Studying hepatitis B infection
  • Testing new antibody-based therapy concepts
  • Supporting better long-term disease control

These trials reflect active interest in advancing antiviral research in Denmark.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.